Reactome: A Curated Pathway Database
THIS SITE IS USED FOR CURATION AND TESTING
IT IS NOT STABLE, IS LINKED TO AN INCOMPLETE DATA SET, AND IS NOT MONITORED FOR PERFORMANCE. WE STRONGLY RECOMMEND THE USE OF OUR PUBLIC SITE

Query author contributions in Reactome

Reactome depends on collaboration between our curation team and outside experts to assemble and peer-review its pathway modules. The integration of ORCID within Reactome enables us to meet a key challenge with authoring, curating and reviewing biological information by incentivizing and crediting the external experts that contribute their expertise and time to the Reactome curation process. More information is available at ORCID and Reactome.

If you have an ORCID ID that is not listed on this page, please forward this information to us and we will update your Reactome pathway records.

Name Email address

Details on Person Hereditary angioedema (HAE) is a rare life-threatening inher...

Class:IdSummation:9657690
_displayNameHereditary angioedema (HAE) is a rare life-threatening inher...
_timestamp2020-01-13 20:26:19
created[InstanceEdit:9657691] Shamovsky, Veronica, 2019-08-09
literatureReference[LiteratureReference:9651455] Novel pathogenic mechanism and therapeutic approaches to angioedema associated with C1 inhibitor deficiency
[LiteratureReference:9650564] The plasma bradykinin-forming pathways and its interrelationships with complement
[LiteratureReference:9651482] High-molecular-weight kininogen cleavage correlates with disease states in the bradykinin-mediated angioedema due to hereditary C1-inhibitor deficiency
[LiteratureReference:9651460] HAE Pathophysiology and Underlying Mechanisms
[LiteratureReference:9653222] Hereditary Angioedema with Normal C1 Inhibitor: Update on Evaluation and Treatment
[LiteratureReference:9653227] A mechanism for hereditary angioedema with normal C1 inhibitor: an inhibitory regulatory role for the factor XII heavy chain
[LiteratureReference:9660300] Hereditary angioedema with normal C1 inhibitor: Four types and counting
[LiteratureReference:9653250] Plasmin is a natural trigger for bradykinin production in patients with hereditary angioedema with factor XII mutations
modified[InstanceEdit:9660299] Shamovsky, Veronica, 2019-09-09
[InstanceEdit:9674513] Shamovsky, Veronica, 2020-01-13
textHereditary angioedema (HAE) is a rare life-threatening inherited edema disorder that is characterized by recurrent episodes of localized edema of the skin or of the mucosa of the gastrointestinal tract or upper airway. The edema formation in patients with HAE is primarily caused by a transient increased bradykinin release from high molecular weight kininogen (HK) due to uncontrolled activation of the coagulation factor XII (FXII)-dependent kallikrein kinin system (KKS) (Bossi F et al. 2009; Kaplan AP 2010; Suffritti C et al. 2014: Zuraw BL & Christiansen SC 2016). Angioedema initiated by bradykinin is usually associated with SERPING1 (C1-INH) deficiency. SERPING1 is the major regulator of the contact system. More rarely, HAE occurs in individuals with normal SERPING1 activity, and has been linked to mutations in other proteins, including FXII, plasminogen, and angiopoietin (Magerl M et al. 2017; Zuraw BL 2018; Ivanov I et al. 2019). Substitution of threonine 328 by either a lysine or an arginine residue (T328K or T328R) in the FXII proline-rich region has been identified in several families with HAE and normal SERPING1. FXII T328K or T328R variants change protein glycosylation and introduce a new site that is sensitive to enzymatic cleavage by fibrinolytic and coagulation proteases such as plasmin, thrombin, or FXIa (de Maat S et al. 2016; Ivanov I et al. 2019). The intrinsic capacity of the truncated form of FXII (329-615) (also known as δFXII) to convert prekallikrein to kallikrein is greater than that of FXII leading to more kallikrein generated early during reciprocal activation (Ivanov I et al. 2019). Second, FXII (329-615) is a better kallikrein substrate than is FXII. The accelerated kallikrein/FXII activation with truncated FXII (329-615) appears to overwhelm the regulatory function of SERPING1 at normal plasma levels leading to uncontrolled bradykinin formation (de Maat S et al. 2016; Ivanov I et al. 2019). Binding of the proinflammatory peptide hormone bradykinin to the bradykinin B2 receptor (B2R) activates various proinflammatory signaling pathways that increase vascular permeability and fluid efflux. An excessive formation of bradykinin due to uncontrolled activation of FXII-dependent KKS causes increased vascular permeability at the level of the postcapillary venule and results in HAE (Zuraw BL & Christiansen SC 2016; de Maat S et al. 2016; Ivanov I et al. 2019).
(summation)[Pathway:9657688] Defective factor XII causes hereditary angioedema [Homo sapiens]
[Change default viewing format]
No pathways have been reviewed or authored by Hereditary angioedema (HAE) is a rare life-threatening inher... (9657690)